Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma

Hepatology

Volumn 50, Issue 3, 2009, Pages 791-798

  Rimola, Jordi ^a   Forner, Alejandro ^b   Reig, Maria ^b   Vilana, Ramon ^a   De Lope, Carlos Rodríguez ^b   Ayuso, Carmen ^a   Bruix, Jordi ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VOLUME; BILE DUCT TUMOR; COMPUTER ASSISTED DIAGNOSIS; LIVER; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

CONTRAST MEDIUM;

AGED; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 70349244859     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23071     Document Type: Article

References (22)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750. (Pubitemid 29114292)
2. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. HEPATOLOGY 2001;33:1353-1357. (Pubitemid 32496970)
3. Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M, et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. HEPATOLOGY 2006;43:1303-1310. (Pubitemid 43980109)
4. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. HEPATOLOGY 2008;48:308-321. (Pubitemid 351975555)
5. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. HEPATOLOGY 2009;49:116-123.
6. Bruix J, Sherman M. Management of hepatocellular carcinoma. HEPATOLOGY 2005;42:1208-1236.
7. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430.
8. Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. HEPATOLOGY 2008;47:97-104. (Pubitemid 351171046)
9. Florie J, Wasser MN, Arts-Cieslik K, Akkerman EM, Siersema PD, Stoker J. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. AJR Am J Roentgenol 2006;186:1384-1392. (Pubitemid 46112577)
10. Maetani Y, Itoh K, Watanabe C, Shibata T, Ametani F, Yamabe H, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001;176:1499-1507. (Pubitemid 32510270)
11. Soyer P, Bluemke DA, Sibert A, Laissy JP. MR imaging of intrahepatic cholangiocarcinoma. Abdom Imaging 1995;20:126-130.
12. Vilgrain V, Van Beers BE, Flejou JF, Belghiti J, Delos M, Gautier AL, et al. Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 1997;21:59-65. (Pubitemid 27061157)
13. Worawattanakul S, Semelka RC, Noone TC, Calvo BF, Kelekis NL, Woosley JT. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging 1998;16:993-1003. (Pubitemid 29189656)
14. Loyer EM, Chin H, DuBrow RA, David CL, Eftekhari F, Charnsangavej C. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT: a comparative study. Radiology 1999;212:866-875. (Pubitemid 29410995)
15. Ito K, Mitchell DG, Hann HW, Kim Y, Fujita T, Okazaki H, et al. Viral-induced cirrhosis: grading of severity using MR imaging. AJR Am J Roentgenol 1999;173:591-596. (Pubitemid 29395273)
16. Marti-Bonmati L, Talens A, del Olmo J, de Val A, Serra MA, Rodrigo JM, et al. Chronic hepatitis and cirrhosis: evaluation by means of MR imaging with histologic correlation. Radiology 1993;188:37-43. (Pubitemid 23183096)
17. Mortele KJ, Ros PR. MR imaging in chronic hepatitis and cirrhosis. Semin Ultrasound CT MR 2002;23:79-100.
18. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371:838-851.
19. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
20. Dietrich CF, Mertens JC, Braden B, Schuessler G, Ott M, Ignee A. Contrast- enhanced ultrasound of histologically proven liver hemangiomas. HEPATOLOGY 2007;45:1139-1145. (Pubitemid 46775775)
21. Fukukura Y, Hamanoue M, Fujiyoshi F, Sasaki M, Haruta K, Inoue H, et al. Cholangiolocellular carcinoma of the liver: CT and MR findings. J Comput Assist Tomogr 2000;24:809-812.
22. Kim SJ, Lee JM, Han JK, Kim KH, Lee JY, Choi BI. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol 2007;189:1428-1434.